Korean J Med.  2004 Sep;67(3):317-320.

A case of ribostamycin-induced anaphylaxis

Affiliations
  • 1Department of Internal Medicine, Eulji University School of Medicine, Daejeon, Korea. lydmd@hanmail.net

Abstract

Anaphylaxis is a life-threatening, systemic reaction manifested by urticaria, angioedema, bronchospasm, syncope and hypotension, which occurs after the exposure to specific antigen such as antibiotics, aspirin, nonsteroidal antiinflammatory drugs, foods, bee sting, or exercise. A 33-year-old woman suffering from anaphylactoid attack after intramuscular administration of ribostamycin at private clinic, was visited to our emergency room and admitted. She had allergic rhinitis and her 8-year-old daughter had atopic dermatitis. She had three previous intramuscular administrations of ribostamycin at every three weeks due to recurrent pelvic inflammatory disease. At third time of ribostamycin administration, she had experienced generalized pruritus, flushing and shortness of breath but these symptoms were resolved spontaneously without medication. Therefore, she didn't notice to attending physician. During the fourth administration of ribostamycin, she developed generalized urticaria and angioedema with dyspnea, dizziness, and severe hypotension. We experienced a case of ribostamycin-induced anaphylaxis, which is rarely mentioned in published articles. We performed a skin prick test and an intradermal test to ribostamycin, which were positive, and report a case of ribostamycin-induced anaphyalxis.

Keyword

Ribostamycin; Anaphylaxis

MeSH Terms

Adult
Anaphylaxis*
Angioedema
Anti-Bacterial Agents
Aspirin
Bees
Bites and Stings
Bronchial Spasm
Child
Dermatitis, Atopic
Dizziness
Dyspnea
Emergency Service, Hospital
Female
Flushing
Humans
Hypotension
Intradermal Tests
Nuclear Family
Pelvic Inflammatory Disease
Pruritus
Rhinitis
Ribostamycin
Skin
Syncope
Urticaria
Anti-Bacterial Agents
Aspirin
Ribostamycin
Full Text Links
  • KJM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr